New Research Explores Link Between High Blood Sugar and Cancer-Fighting Immune Cells

A study published in The Journal of Immunology indicates that elevated blood sugar may enhance the tumor-fighting capabilities of immune cells. Researchers investigated why individuals with type 1 diabetes appear to have a lower risk for certain cancers, such as melanoma and breast cancer.

In laboratory experiments, mice with high blood sugar levels exhibited slower tumor growth compared to those with normal or insulin-controlled levels. The hyperglycemic mice showed an increased number of T cells that were more effective at managing tumor development.

The study identified that high blood sugar alters a specific cellular signaling pathway, which boosts immune cell activity. When insulin was administered to the mice, this enhanced function was lost, highlighting a connection between glucose levels and immune performance.

Researchers observed similar signaling activity in human blood samples, suggesting the mechanism could be relevant to people. However, the authors noted that further research is required to determine if these pathways can be safely targeted for human cancer therapies.